Poolbeg Pharma PLC (AIM: POLB)
11.10
-0.15 (-1.33%)
Sep 10, 2024, 4:15 PM GMT+1
Poolbeg Pharma Statistics
Total Valuation
Poolbeg Pharma has a market cap or net worth of GBP 55.50 million. The enterprise value is 43.33 million.
Market Cap | 55.50M |
Enterprise Value | 43.33M |
Important Dates
The next estimated earnings date is Friday, September 13, 2024.
Earnings Date | Sep 13, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Poolbeg Pharma has 500.00 million shares outstanding.
Shares Outstanding | 500.00M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 11.93% |
Owned by Institutions (%) | 46.54% |
Float | 426.83M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | 3.84 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -11.02 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 13.69
Current Ratio | 13.69 |
Quick Ratio | 13.01 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -24.00% and return on invested capital (ROIC) is -17.88%.
Return on Equity (ROE) | -24.00% |
Return on Assets (ROA) | -16.87% |
Return on Capital (ROIC) | -17.88% |
Revenue Per Employee | n/a |
Profits Per Employee | -262,067 |
Employee Count | 15 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +57.45% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +57.45% |
50-Day Moving Average | 12.48 |
200-Day Moving Average | 11.07 |
Relative Strength Index (RSI) | 30.26 |
Average Volume (20 Days) | 590,782 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -4.69M |
Pretax Income | -4.51M |
Net Income | -3.93M |
EBITDA | -4.66M |
EBIT | -4.69M |
Earnings Per Share (EPS) | -0.01 |
Balance Sheet
Cash & Cash Equivalents | 12.17M |
Total Debt | n/a |
Net Cash | 12.17M |
Net Cash Per Share | 0.02 |
Equity (Book Value) | 14.44M |
Book Value Per Share | 0.03 |
Working Capital | 12.51M |
Cash Flow
Operating Cash Flow | -4.38M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Poolbeg Pharma does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -7.12% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |